Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TERI-PRO: Teriflunomide in Relapsing Multiple Sclerosis
NCT01895335Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2013
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 4 trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Started Jun 2013; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01895335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01895335.